checkAd

    DGAP-News  4896  0 Kommentare MeVis Medical Solutions AG: Successful start into the new fiscal year - Seite 2



    The reduction in personnel expenses by -13 % to EUR 1.8 million (prev. year: EUR 2.0 million) was mainly attributable to provisions for special payments in the previous year. Operating costs fell significantly in the first quarter of 2017; other operating expenses decreased in the first quarter compared to the same quarter last year to EUR 0.5 million (prev. year: EUR 0.8 million), mainly due to the provision recognized in the previous year for litigation costs.



    This results in an EBIT (earnings before interest and taxes) of EUR 2.9 million compared to EUR 0.9 million in the prior-year period. At 52 %, the EBIT margin more than doubled compared to prior-year's figure.



    The financial result significantly improved compared to the previous year with now EUR 1.6 million. This was mainly due to the effects of the development of US$ in connection with a high proportion of US dollars in the available liquidity.



    Due to the fiscal unity, which became effective as of January 1, 2016, the tax result consists solely of the withholding tax of EUR 13 k. After-tax earnings consequently rose to EUR 4.4 million, which is equivalent to undiluted earnings per share of EUR 2.43 (prev. year: EUR 2.07).



    The Annual General Meeting will take place on March 8, 2017. The interim financial statement for the first half year 2017 will be published on May 18, 2017.















    21.02.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de





























    Language: English
    Company: MeVis Medical Solutions AG
    Caroline-Herschel-Str. 1
    28359 Bremen
    Germany
    Phone: +49 421 224 95 0
    Fax: +49 421 224 95 999
    E-mail: ir@mevis.de
    Internet: http://www.mevis.de
    ISIN: DE000A0LBFE4
    WKN: A0LBFE
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange





     
    End of News DGAP News Service





    546079  21.02.2017 




    Seite 2 von 2


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News MeVis Medical Solutions AG: Successful start into the new fiscal year - Seite 2 DGAP-News: MeVis Medical Solutions AG / Key word(s): Interim Report/Quarter Results MeVis Medical Solutions AG: Successful start into the new fiscal year 21.02.2017 / 14:00 The issuer is solely responsible for the content of this announcement. …